Fig. 3.
Extent of cell infiltration in tumor biopsies at baseline and during treatment (day 29) with vanucizumab for patients with a documented best overall response of progressive disease (PD) or stable disease (SD)a (n = 17) aNon-paired data points are shown for completeness where data points are missing. CD, cluster of differentiation.